Cost-Effectiveness of Insulin Glargine/Lixisenatide Titratable Fixed-Ratio Combination for Patients with Basal Insulin-Treated Type 2 Diabetes in South Korea
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.292
https://www.valueinhealthjournal.com/article/S1098-3015(18)32649-4/fulltext
Title :
Cost-Effectiveness of Insulin Glargine/Lixisenatide Titratable Fixed-Ratio Combination for Patients with Basal Insulin-Treated Type 2 Diabetes in South Korea
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32649-4&doi=10.1016/j.jval.2018.07.292
First page :
Section Title :
Open access? :
No
Section Order :
258